© 2026 New England Public Media

FCC public inspection files:
WGBY • WFCR • WNNZ • WNNU • WNNZ-FM • WNNI

For assistance accessing our public files, please contact hello@nepm.org or call 413-781-2801.
PBS, NPR and local perspective for western Mass.
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Neurontin

NPR | By Snigdha Prakash,
Michele Norris
Published December 19, 2002 at 12:00 AM EST

Michele Norris talks with NPR's Snigdha Prakash about actions by drug company Parke-Davis to promote the drug Neurontin for uses not yet approved by the government. NPR has obtained documents indicating that Tony Wild, then-president of Parke-Davis, was aware of the plan to work around FDA approval to promote the drug.

Copyright 2002 NPR
Snigdha Prakash
Pieces by National Desk reporter Snigdha Prakash can be heard on NPR's All Things Considered and Morning Edition. The majority of Snigdha's past reports have focused on topics related to entrepreneurship, business, banking and the economy.
Michele Norris